Bharat Biotech's COVID-19 vaccine, Covaxin, has no serious side effects, says The Lancet

However, the report made it clear that efficacy cannot be determined by phase 2 trials and this required further corroboration with phase 3 safety results.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3rBDD5O
via IFTTT